Connect with us

Cannabis

Study Shows Cannabis Provides Relief To 9 Out Of 10 Migraine Patients

Avatar

Published

on

A study from researchers at the University of New Mexico has found that more than nine out of 10 migraine patients reported that inhaled cannabis provided relief for their symptoms. A report on the research, titled “Alleviative effects of cannabis flower on migraine and headache,” was published this month in the Journal of Integrative Medicine.

To conduct the study, researchers tracked the effects of inhaled herbal cannabis on the symptoms experienced by 699 migraine sufferers over a period of 32 months. Participants self-administered cannabis while at home and reported their use and its effect on symptoms via the smartphone application Releaf. The intensity of pain related to migraine or headache was measured on a scale of zero to ten prior to and immediately following cannabis consumption.

“According to the current results, cannabis flower appears to be effective at reducing headache- and migraine-related pain intensity for most people that choose to use it,” the authors of the study wrote.

“It seems possible that the use of cannabis flower, combined with other behavioral modifications, might offer some patients a natural, safer, and more effective treatment regimen, compared to the use of some conventional prescription pharmaceuticals,” they added.

The study found that 94% of participants reported relief of symptoms within two hours of cannabis inhalation. On average, study participants experienced a reduction of 3.3 points on the ten-point scale. Varieties of cannabis with a THC content of 10% or higher were found to be most effective at relieving migraine symptoms. Males tended to achieve greater relief than females, and younger participants reported greater benefit than older patients.

“These results suggest that whole dried Cannabis flower may be an effective medication for treatment of migraine- and headache-related pain, but the effectiveness differs according to characteristics of the Cannabis plant, the combustion methods, and the age and gender of the patient,” the researchers concluded.

Research Reveals More Evidence Of The Entourage Effect

Researcher Jegason Diviant, who worked on the migraine study as well as another one that used the Releaf app to track the effect of cannabis on depression, reported that many patients are experiencing better results with whole cannabis flower than those reported with refined cannabinoid formulations. The findings give further credence to the entourage effect widely associated with cannabis use.

“We are seeing very encouraging evidence that cannabis can be safe and effective for treating both depression and chronic pain,” Diviant said. “Phytocannabinoid isolates, such as THC or CBD, are less effective treatment options than whole-spectrum cannabis products. However, it is not enough to simply educate the public that whole-spectrum cannabis is superior to cannabis-derived isolates. There are thousands of cannabis strains, also known as chemotypes or chemovars, and they all have a unique phytocannabinoid and terpene profile.”

The researcher noted the wide range of effects that different varieties of cannabis can provide and urged a change in federal cannabis policy to spur more study.

“I predict that we will identify specific chemotypes that are optimal for treating various mental and physical health disorders as well as chemotypes that may be contraindicated for these disorders,” Diviant added. “This research is critical and essential for public health, and for us to properly conduct this vital research, the Schedule I classification must be lifted.”

Source: https://hightimes.com/news/study-shows-cannabis-provides-relief-migraine-patients/?utm_source=rss&utm_medium=rss&utm_campaign=study-shows-cannabis-provides-relief-migraine-patients

Cannabis

Cannabis and the 2020 Election

Avatar

Published

on

Next month, five states will be voting on seven ballot measures to legalize cannabis. A variety of proposals, including constitutional amendments, statutory initiatives, and alternative measures, could establish new medical cannabis markets in two states and expand legalization to include adult use legalization in four states. Three of these proposals would enshrine cannabis possession and consumption within state constitutions.

This article will explore the proposals themselves as well as the short-term implications of legalization on existing license holders and the industry.

2020 cannabis ballot measures policy focus

State-by-State Review

Arizona

Arizona voters have another opportunity to legalize cannabis next month, after narrowly defeating adult use legislation four years ago. In recent years, the Copper State’s medical cannabis market has seen significant MSO expansion, and new mandatory testing requirements launch at the beginning of November.

There are roughly 150 medical cannabis licenses in the state currently — all of which would receive priority status in the application process for adult use licensing. Additionally, diversity applicants and applicants in areas currently lacking cannabis retail access would be fast-tracked applicants.

Prop. 207 does include local control and opt-out provisions, and a new 16% tax would direct revenue to a variety of funds, while retail operators would be able to launch delivery services as soon as 2023.

Mississippi

Mississippi could become the 34th state to legalize cannabis for medical use, but two competing measures are creating complications on the ballot. A citizen-driven campaign led to the placement of Initiative 65, while the legislature responded with Alternative Initiative 65A.

Initiative 65 establishes a medical cannabis program similar to the program structure of many other states; with clearly defined qualifying conditions, possession limits, taxes, registration fees, and a regulator — the state health department. The alternative includes no definitions and only allows smokable cannabis products for terminally ill patients, leaving a highly restrictive market requiring enabling legislation.

Previous bills have been proposed, but never brought to a vote — leaving some skeptical that anything at all may come of Initiative 65A.

Montana

Montana’s existing medical cannabis program relies on a system of caregivers who cultivate cannabis and make manufactured products, including edibles and concentrates. Additionally, there is a limited number of licensed dispensaries throughout the state. Legalization would be a major evolution for Montana, which has seen multiple ballot initiatives and legislative interventions in recent years.

Two measures have been placed: one constitutional amendment to set the age of 21 as the minimum buying age and a measure to establish a commercial adult use market. While no early sales provisions are included, Montana companies would be the only businesses able to start sales for the first year after legalization.

New Jersey

New Jersey voters may make history, legalizing the adult use of cannabis and triggering a race among Mid-Atlantic states to implement sales first. While all of New Jersey’s neighbors have existing medical cannabis programs, none have taken steps to expand further. In recent years, numerous regional state legislatures have attempted to legalize, and Public Question 1 may tip the scales for an entire region with over 50 million residents.

The text of the amendment is brief, but it establishes a definition for ‘cannabis’ while permitting possession, use, and industry operations for adults ages 21 and up. The existing Cannabis Regulatory Commission would be tasked with regulating the industry, but the state legislature must first come to an agreement and pass enabling legislation.

Currently, New Jersey’s medical market includes roughly fifteen licenses, including cultivation and manufacturing, as well as a limited number of dispensaries. The next phase for cannabis in NJ is uncharted territory for now: it is unclear if existing licenses will be given the first opportunity to serve the general public.

Given licensing delays and a slow rollout in Illinois, lawsuits and delays could be in New Jersey’s future — with some analysts suggesting a four-year timeline from amendment passage to full implementation. This may be good news for MSOs, including Columbia Care, Verano, and Acreage Holdings, among others.

South Dakota

South Dakota has long been unfriendly to cannabis in all forms and has some of the nation’s strictest marijuana possession penalties. While other non-medical states have at least given a nod to low-THC medical hemp programs, the Mount Rushmore state hadn’t established any kind of hemp or cannabis program at all until the legislature passed industrial hemp legalization this past spring.

Now, the state could make history as the first to legalize cannabis for medical and adult use purposes at the same time. Two proposals are on the ballot: an initiated measure to launch a medical cannabis program, and a constitutional amendment to fully legalize cannabis, with provisions including adult use, a medical program, and expanded hemp legalization.

Medical use is enshrined in both proposals, while the constitutional amendment would prevent the legislature from any type of statutory tampering to limit a retail market. The constitutional amendment would establish a commercial market for both adult use and medical purposes. Medical use would include home cultivation. As there is no cannabis market in the state at this time, no businesses would be able to take advantage of “early sales” provisions, as seen in other states.

Analysis

Previously, medical cannabis programs and commercial licensing schemes predated adult use legalization, and the majority of these proposals came into existence by way of the ballot. In most of the earliest states to fully legalize, this was the case: Colorado, Washington, Alaska, Oregon, California, Massachusetts, and Nevada all had some form of voter-approved medical cannabis legislation first.

Implementation of adult-use legalization has, however, varied across the states. In these proposals, Arizona, Montana, and New Jersey have existing medical cannabis infrastructures, but the implementation of adult use will likely lead to program changes.

Some legalization measures have allowed for existing medical dispensaries to launch sales to adults during a period of late-stage rulemaking. These businesses have operated under modified compliance rules, with track-and-trace requirements and varying tax rates until legalization rules are completed.

After Oregon voters approved legalization in 2014, the state’s medical market rapidly expanded with early sales on the horizon. At one point, there were more medical dispensaries in the state than Starbucks or McDonald’s locations. That number later dropped as businesses converted their licenses over.

For some of the states with legalization on the ballot this year, the transition out of medical will pose challenges: product shortages, long customer lines, new tax rates, uncertainty over product offerings, and testing requirements on top of an already difficult pandemic business environment.

Overall, legalization measures promise to bring a significant impact to consumers and patients in Arizona, Mississippi, Montana, New Jersey, and South Dakota. It’s hard to quantify the short-term improvements to consumers and industry operators, as passage of these initiatives will set off a flurry of legislative and regulatory discussion over the holidays and into the spring. Existing licensees and hopeful applicants should keep an eye for new opportunities: public comment periods, application deadlines, and new sales opportunities on the horizon.

Source: https://cannabiz.media/cannabis-and-the-2020-election/

Continue Reading

Cannabis

Cuomo advisor predicts New York will legalize pot in April

Avatar

Published

on

New York Governor Andrew Cuomo’s advisor on marijuana policy said this week the Empire State could legalize weed in April of next year with a bill that would serve as a model for other states looking to allow recreational pot in the United States.

Axel Bernabe, assistant counselor to Governor Cuomo, was a guest on the Under The Canopy series, recently launched by Canopy Growth, where he discussed cannabis legalization efforts in New York. According to Bernabe, a bill to legalize marijuana will be introduced through the state budget in January again, while he expects legalization to take effect by April. 

As New Jersey appears ready to legalize marijuana this November, Bernabe said the Cuomo administration has been watching its neighbor “closely.”

“We’re watching New Jersey closely. We’ve always been confident that we’d get to this before New Jersey, so if they pass the referendum they still have to have an agreement between the governor and the Senate over there,” he said.

“If New Jersey can beat us to it, they’ll get a gold star but I still think we’re gonna set the model for this,” Bernabe added, referring to the bill’s social equity provisions, among other things. 

During the interview, Bernabe also said that New York has been monitoring how legalization has been unfolding in Vermont, Maine, and Massachusetts, but has also consulted with states on the West Coast, where the legal pot industry is larger and more developed. 

Regarding hemp, Cuomo’s advisor said the state will release its guidelines and regulations for CBD consumer products early next year as well.

“Those products are already out there, so there’s no sense in pretending they’re not,” Bernabe explained. 

For this reason, the governor and his team have been working on guidelines, which will include maximum dose per serving labeling and warnings about potential THC content in various hemp-derived products. New York has copied a lot of Florida’s hemp regulations while crafting its own policies, Bernabe stated, before telling Canopy Growth’s David Culver that the administration is currently putting the finishing touches to the guidelines. 

Although Governor Cuomo promised his state would legalize weed soon, marijuana legalization was left out of the New York state budget for 2020 due to the coronavirus pandemic, which hit the state particularly badly earlier this year.

Cuomo previously proposed working in conjunction with the neighboring states of New Jersey, Connecticut, and Pennsylvania on coordinating a recreational marijuana system for the region. 

Source: https://greencamp.com/cuomo-advisor-predicts-new-york-will-legalize-pot-in-april/

Continue Reading

Cannabis

PURA Concludes Farmersville Meetings – Deal Imminent

Avatar

Published

on

Dallas, TX – October 20, 2020 – OTC PR WIRE — Puration, Inc. (OTC PINK: PURA) today announced that CEO Brian Shibley concluded a key meeting yesterday essential to finalizing the acquisition of 72-acre property in Farmersville, Texas central to the company’s recently announced Farmersville Brands strategy.  “The acquisition is imminent. Look for an announcement very soon,” said Mr. Shibley.

PURA has scheduled the release of a comprehensive update this Friday, October 23, 2020, to provide the latest information on progress with the Farmersville Brand strategy. The Friday update this Friday will include the latest on the company’s planned dividend of PAO Group, Inc. (OTC PINK: PAOG) stock in conjunction with PURA’s sale of its cannabis cultivation business to PAOG.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

Source: https://otcprwire.com/pura-concludes-farmersville-meetings-deal-imminent/

Continue Reading
Energy6 hours ago

Global Electrical SCADA Market Report 2020: Developments in IoT Technology and Cloud Computing has Increased Growth

Energy7 hours ago

Global $855 Billion Bio-Refinery Product Market to 2026 with Neste Oil, Renewable Energy, Pacific Ethanol, UOP, Abengoa Bioenergy, and Valero Energy Dominating

Energy7 hours ago

U.S. Chemical Production Expanded In September

Energy7 hours ago

$9.8 Billion Worldwide Thermal Spray Coatings Industry to 2027 – Impact of COVID-19 on the Market

Energy7 hours ago

Valisure Expands Testing Capabilities With The Addition Of Elemental Analysis

AR/VR8 hours ago

Somnium Space’s Next Updates to Add Buildable Worlds, Web Access & More

AI8 hours ago

Beyond Limits and The Carnrite Group Create Alliance to Drive AI Innovation in Oil & Gas, Utilities, Power and Industrial Sectors.

Esports8 hours ago

BIG, OG, fnatic round out Flashpoint 2 team list

Crowdfunding9 hours ago

Earn $10,249 a Year in FREE “Crypto Income”

Energy10 hours ago

Ball Corporation and Kroenke Sports & Entertainment Announce Global Partnership to Advance Sustainability in Sports and Entertainment Through Aluminum Beverage Packaging, Improved Recycling Programs and Consumer Education

Energy10 hours ago

St. James Gold Announces Private Placement

Energy10 hours ago

Worldwide Water and Wastewater Treatment Equipment Industry to 2027 – Featuring SUEZ, Ecolab & DuPont Among Others

Energy10 hours ago

Automotive Refinish Coatings Market Size Worth USD 11.69 Billion by 2027 | CAGR of 3.7%: Emergen Research

AR/VR10 hours ago

Captain Toonhead vs the Punks from Outer Space Unleashes FPS Tower Defense in 2021

Germany
Esports10 hours ago

Vitality take down BIG to set up clash against Astralis in DH Open Fall

Energy13 hours ago

Dorian LPG Ltd Provides Update for the Second Quarter 2021 and Announces Second Quarter 2021 Earnings and Conference Call Date

Energy13 hours ago

SK Innovation Declares Ambition to ‘Lead the Efforts for Battery Safety, Charging Speed and Driving Range’ at InterBattery 2020

Energy13 hours ago

Canada Nickel Makes Third New Discovery at Crawford Nickel-Cobalt Sulphide Project

Energy13 hours ago

AEP Reports Strong Third-Quarter 2020 Earnings

Blockchain16 hours ago

Eyeing EU Banks, Hex Trust Teams With SIA on Crypto Custody

Blockchain16 hours ago

Collider Labs Raises $1M to Invest in Blockchain Startups

Blockchain18 hours ago

Voyager Agrees to Buy LGO Markets and Merge 2 Firms’ Tokens

Cyber Security24 hours ago

Business Enablement By Way Of The BISO

Ecommerce24 hours ago

Turing Pi 2 – compact edge clusters with 32 GB RAM and new Raspberry…

Ecommerce24 hours ago

The Top eCommerce Companies in October, According to eCommerce…

Ecommerce24 hours ago

Footwear Manufacturer Otabo Steps Up Digital Strategy with Centric…

Ecommerce24 hours ago

Cloud Sales Veterans Release Essential Read for B2B Salespeople

Ecommerce24 hours ago

LaserShip Announces Its Time Of Need Philanthropic Program

Indonesia
Esports1 day ago

Gen.G in talks with Liazz – Report

Esports1 day ago

cogu joins MIBR as manager and coach

Energy1 day ago

Strategic Resources Files Mustavaara Technical Report

Energy1 day ago

Ur-Energy Announces Extension of State Bond Loan and Provides Update

Energy1 day ago

Pettit Marine Paint Develops the Most Effective Anti-fouling Paint to Hit the Market in Many Years – ODYSSEY® TRITON

Energy1 day ago

Core Lab Reports Third Quarter 2020 Results From Continuing Operations:

Blockchain1 day ago

Pelosi, Kudlow Signal Market-Moving US Stimulus May Wait Till After Election: Report

Energy1 day ago

A Difference-Making Disinfectant

Blockchain1 day ago

Market Wrap: PayPal Powers Bitcoin Past $12.8K as Ether Dominance Drops

Automotive1 day ago

How Car Tires Are Manufactured

Medical Devices1 day ago

5 Real World Applications of the Doppler Effect

Big Data1 day ago

Join Hands with Instagram’s New Algorithm to Boost Your Business’s User Engagement

Trending